Related Experiment Video
Updated: Jun 19, 2026

Magnetic-, Acoustic-, and Optical-Triple-Responsive Microbubbles for Magnetic Hyperthermia and Pothotothermal Combination Cancer Therapy
Published on: May 22, 2020
Metal-organic framework-based smart stimuli-responsive drug delivery systems for cancer therapy: advances,
Ziliang Guo1, Yuzhen Xiao2, Wenting Wu3
1Division of Thyroid and Parathyroid Surgery, West China Hospital, Sichuan University, Chengdu, 610041, China.
Abstract:
Cancer treatment is currently one of the most critical healthcare issues globally. A well-designed drug delivery system can precisely target tumor tissues, improve efficacy, and reduce damage to normal tissues. Stimuli-responsive drug delivery systems (SRDDSs) have shown promising application prospects. Intelligent nano drug delivery systems responsive to endogenous stimuli such as weak acidity, complex redox characteristics, hypoxia, active energy metabolism, as well as exogenous stimuli like high temperature, light, pressure, and magnetic fields are increasingly being applied in chemotherapy, radiotherapy, photothermal therapy, photodynamic therapy, and various other anticancer approaches. Metal-organic frameworks (MOFs) have become promising candidate materials for constructing SRDDSs due to their large surface area, tunable porosity and structure, ease of synthesis and modification, and good biocompatibility. This paper reviews the application of MOF-based SRDDSs in various modes of cancer therapy. It summarizes the key aspects, including the classification, synthesis, modifications, drug loading modes, stimuli-responsive mechanisms, and their roles in different cancer treatment modalities. Furthermore, we address the current challenges and summarize the potential applications of artificial intelligence in MOF synthesis. Finally, we propose strategies to enhance the efficacy and safety of MOF-based SRDDSs, ultimately aiming at facilitating their clinical translation.
Insights
Metal-organic frameworks (MOFs) are advanced materials for stimuli-responsive drug delivery systems (SRDDSs) in cancer therapy. This review explores MOF-based SRDDSs, their mechanisms, and future clinical translation potential.
Area of Science:
- Materials Science
- Nanotechnology
- Oncology
Background:
- Cancer treatment demands precise drug delivery to enhance efficacy and minimize side effects.
- Stimuli-responsive drug delivery systems (SRDDSs) offer targeted therapeutic approaches.
- Metal-organic frameworks (MOFs) present unique properties for advanced drug delivery applications.
Purpose of the Study:
- To review the application of MOF-based SRDDSs in diverse cancer therapy modalities.
- To summarize the synthesis, modification, and stimuli-responsive mechanisms of MOF-based SRDDSs.
- To discuss challenges and future directions, including AI in MOF synthesis for improved cancer treatment.
Main Methods:
- Literature review of MOF-based SRDDSs in cancer therapy.
- Analysis of stimuli-responsive mechanisms (endogenous and exogenous).
- Exploration of MOF synthesis, modification, and drug loading strategies.
Main Results:
- MOFs are versatile platforms for constructing SRDDSs due to their tunable properties.
- MOF-based SRDDSs effectively target tumors and respond to various stimuli for controlled drug release.
- Applications span chemotherapy, radiotherapy, photothermal, and photodynamic cancer therapies.
Conclusions:
- MOF-based SRDDSs show significant promise for advanced cancer treatment.
- Addressing current challenges and integrating AI can accelerate the clinical translation of these systems.
- Further research is needed to optimize efficacy and safety for patient benefit.
Related Concept Videos
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Drug Delivery Systems: Different Types
Modified-Release Drug Delivery Systems: Classification
Modified-Release Drug Delivery Systems: Stimuli-Activated
Modified-Release Drug Delivery Systems: Site-Targeted
Site-Targeted Drug Delivery Systems: Polymeric Carriers

